LUX HEALTH TECH ACQUISITION - COM CL A (LUXA)

CUSIP: 55068A100

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM CL A
Total 13F shares
27,064,688
Share change
+3,773,516
Total reported value
$265,245,000
Put/Call ratio
31%
Price per share
$9.80
Number of holders
58
Value change
+$36,930,058
Number of buys
22
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 55068A100?
CUSIP 55068A100 identifies LUXA - LUX HEALTH TECH ACQUISITION - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) as of Q4 2021

As of 31 Dec 2021, LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,064,688 shares. The largest 10 holders included Empyrean Capital Partners, LP, Weiss Asset Management LP, Wolfswood Holdings, LLC, Senator Investment Group LP, Beryl Capital Management LLC, MARSHALL WACE, LLP, MILLENNIUM MANAGEMENT LLC, Balyasny Asset Management LLC, RP Investment Advisors LP, and MYDA Advisors LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.